Onsdag 28 Oktober | 21:01:43 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Carasent - Focus on Investments

2022-03-02 11:00:00

Redeye updates its estimates for 2022 following the Q4 report, and comments on various subjects, ranging from organic growth, net revenue retention, Medrave, Webdoc X/NO, and political risks in the case.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/